Premier Inc., through its ProvideGx program, has partnered with Somerset Pharma LLC., to supply sulfamethoxazole/trimethoprim, an antibiotic combination used to treat respiratory infections, a common complication associated with COVID-19.   Sulfamethoxazole/trimethoprim is not in active shortage today, but it is a drug category that lacks competition, which can make it vulnerable to price increases and potential shortages. Somerset is a new market entrant for this drug, working to creating a via...